Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
五味化痔胶囊治疗痔(湿热壅滞证)有效性及安全性的随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial on the efficacy and safety of Wuwei Huazhi Capsule in the treatment of hemorrhoids (damp-heat stagnation syndrome)
以便血消失时间为主要疗效指标,确证五味化痔胶囊治疗痔(湿热壅滞证)的有效性,同时观察本品的安全性,为本品注册申请的审查提供依据。
[Translation] The time for disappearance of bleeding in stool was used as the main efficacy indicator to confirm the effectiveness of Wuwei Huazhi Capsule in treating hemorrhoids (damp-heat stagnation syndrome). At the same time, the safety of this product was observed to provide a basis for the review of the registration application for this product.
100 Clinical Results associated with Shijiazhuang Zangnuo Biotechnology Co., Ltd.
0 Patents (Medical) associated with Shijiazhuang Zangnuo Biotechnology Co., Ltd.
100 Deals associated with Shijiazhuang Zangnuo Biotechnology Co., Ltd.
100 Translational Medicine associated with Shijiazhuang Zangnuo Biotechnology Co., Ltd.